The consistency evaluation of amoxicillin capsule

On December 2, Anke Hengyi, a wholly-owned subsidiary of Anke biology, received the approval document for supplementary drug application of amoxicillin capsule approved and issued by the State Food and Drug Administration with the approval number of 2019b0 * * 7 After examination, amoxicillin capsule of ankehengyi passed the consistency evaluation of quality and efficacy of generic drugs At the same time, the State Food and Drug Administration agreed to change the prescription process and revise the quality standard of the drug Amoxicillin capsule is mainly used for infectious diseases in adults and children caused by sensitive bacteria (strains that do not produce β lactamase) The original research company of amoxicillin capsule is GSK This product is sold in most countries in the world Amoxicillin Capsules of Zhuhai United Pharmaceutical Co., Ltd., Shiyao group and Hunan Kelun Pharmaceutical Co., Ltd have passed the consistency evaluation in China Amoxicillin is a broad-spectrum β - lactam antibiotic of penicillin It has strong antibacterial and bactericidal effects on most of the pathogenic Gram-positive and Gram-negative bacteria It is widely used in the treatment of upper respiratory tract infection, urogenital tract infection, skin and soft tissue infection, lower respiratory tract infection caused by sensitive bacteria and in combination with other drugs to eradicate Helicobacter pylori, and it is light and medium There is no need to adjust the dosage in patients with DN It is widely recommended by authoritative guidelines and consensus such as diagnosis and treatment of adult community acquired pneumonia in China (2016 Edition) and guidelines for clinical application of antibiotics (2015 Edition) Amoxicillin capsule has entered the category a medical insurance and national basic drug catalog in 2018 Adorable adorable